Medicare Compliance & Reimbursement - 2016 Issue 31
Focus on Melanoma: Malignant and In Situ Are Different Diagnosis Code Options
Subscribe or sign in to view the full article.
Article Overview
This article explains how melanoma-related diagnoses are organized across multiple ICD-10-CM code families and why the documentation details matter. It is aimed at coders, auditors, and billing staff who need a broad understanding of how melanoma coding is divided among primary malignant, in situ, and metastatic categories, along with site- and laterality-based coding considerations.
Why This Topic Matters
Melanoma does not map to a single diagnosis family, so accurate code-family selection is important for consistent reporting and claims processing. The article helps readers understand the scope of melanoma coding distinctions covered in ICD-10-CM and where documentation details influence code selection.
Article Sections
-
Turn Here for Primary Malignant Melanoma
Introduces the ICD-10-CM family used for primary malignant melanoma and discusses the role of body site, laterality, and stage information in code selection.
-
In Situ is Different
Covers the separate ICD-10-CM family used for melanoma in situ and describes how site and laterality affect coding within that category.
-
Look Elsewhere for Secondary Metastatic Tumor
Reviews the ICD-10-CM families used when melanoma is reported as secondary or metastatic to other sites, including lymph nodes and organs.
What You Will Learn
- How melanoma diagnosis coding is divided across multiple ICD-10-CM families
- How documentation of site, laterality, and stage affects melanoma diagnosis coding
- How melanoma in situ is distinguished from malignant melanoma in coding
- How secondary metastatic melanoma is categorized in ICD-10-CM
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Revenue cycle professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com